References: Slamon DJ, Neven P, Chia S, et al. Overall Survival With Ribociclib Plus Fulvestrant in Advanced Breast Cancer. N Engl J Med. 2020 Feb 6;382(6):514-524. KISQALI Prescribing Information Nov 2019.SIN Novartis Singapore.